Bioactive Peptide <scp>HX</scp> ‐ <scp>12C</scp> Ameliorates Oral Submucous Fibrosis via Inhibition of <scp>TGF</scp> ‐β/Smad‐Driven Myofibroblast Activation: A Potential Therapeutic Strategy

Weiman Huang, Rujie Shi, Yujing Wang, Xidi Wang, Zuodong Qin, Xiaofang Luo, Kun Li, Baisheng Wang, Yanjia Hu

Open source

DOI: 10.1111/odi.70569
Published: 2026-11-10
Container: Oral Diseases
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/odi.70569,
  title = {Bioactive Peptide
                    <scp>HX</scp>
                    ‐
                    <scp>12C</scp>
                    Ameliorates Oral Submucous Fibrosis via Inhibition of
                    <scp>TGF</scp>
                    ‐β/Smad‐Driven Myofibroblast Activation: A Potential Therapeutic Strategy},
  author = {Weiman Huang and Rujie Shi and Yujing Wang and Xidi Wang and Zuodong Qin and Xiaofang Luo and Kun Li and Baisheng Wang and Yanjia Hu},
  year = {2026},
  journal = {Oral Diseases},
  doi = {10.1111/odi.70569},
  url = {https://doi.org/10.1111/odi.70569}
}

RIS

TY  - JOUR
TI  - Bioactive Peptide
                    <scp>HX</scp>
                    ‐
                    <scp>12C</scp>
                    Ameliorates Oral Submucous Fibrosis via Inhibition of
                    <scp>TGF</scp>
                    ‐β/Smad‐Driven Myofibroblast Activation: A Potential Therapeutic Strategy
AU  - Weiman Huang
AU  - Rujie Shi
AU  - Yujing Wang
AU  - Xidi Wang
AU  - Zuodong Qin
AU  - Xiaofang Luo
AU  - Kun Li
AU  - Baisheng Wang
AU  - Yanjia Hu
PY  - 2026
JO  - Oral Diseases
DO  - 10.1111/odi.70569
UR  - https://doi.org/10.1111/odi.70569
ER  -

APA

Huang, W., Shi, R., Wang, Y., Wang, X., Qin, Z., Luo, X., Li, K., Wang, B., & Hu, Y. (2026). Bioactive Peptide <scp>HX</scp> ‐ <scp>12C</scp> Ameliorates Oral Submucous Fibrosis via Inhibition of <scp>TGF</scp> ‐β/Smad‐Driven Myofibroblast Activation: A Potential Therapeutic Strategy. Oral Diseases. https://doi.org/10.1111/odi.70569

Source records

crossref · retrieved 2026-11-10T19:03:12.679Z